Table 1.

Cancer screening rates of the five major cancers in Korea, 2004-2010

APC, annual percent change; CI, confidence interval; UGI, upper gastrointestinal; DCBE, double-contrast barium enema; FOBT, fecal occult blood test. ^a)Lifetime screening rate was defined as the proportion of respondents who ever underwent the screening test(s), ^b)Recommended screening rate was defined as the proportion of respondents who fulfilled the screening recommendation criteria among the respondents in the targeted age group for the relevant cancer, ^c)Respondents were restricted to those whose last screening upper endoscopy or UGI series was performed within 2 years among men and women aged 40 years and over, ^d)Respondents were restricted to examinees whose last screening with abdominal ultrasonography and serum α-fetoprotein was performed within 1 year among men and women aged 40 and over at high risk for liver cancer [hepatitis B virus surface antigen (+), hepatitis C virus antibody (+), or liver cirrhosis], ^e)Respondents were restricted to examinees whose last screening with colonoscopy, DCBE, or FOBT was undergone within 1, 5, or 10 years, respectively, among men and women aged 50 and over. However, the question asked about the last screening without consideration of colonoscopy and DCBE within 5 years during 2004-2008, ^f)Respondents were restricted to examinees whose last screening with mammography was performed within 2 years among women aged 40 and over, ^g)Respondents were restricted to examinees whose last screening with conventional cytology was undertaken within 2 years among women aged 30 and over, ^h)Screening rates in parentheses are modality-specific rates.